PURPOSE: Patients with gallbladder cancer tend to have advanced, unresectable tumor at the time of presentation and they face a dismal prognosis in the absence of a standard chemotherapy regimen. This study was performed to evaluate the outcomes of patients with gallbladder cancer and who underwent postoperative gemcitabine-based chemotherapy. METHODS: From March of 2001 to February of 2008, a total of 27 patients underwent operation for gallbladder cancer. They underwent two types of gemcitabine-based chemotherapy. One type of regimen was the combined administration of gemcitabine 1,000 mg/m2 and 5-fluorouracil 200 mg/m2. The other one was combined administration of gemcitabine 1,000 mg/m2 and cisplatin 70 mg/m2. RESULTS: Among the 27 patients, 15 patients were treated with gemcitabine-based chemotherapy and 12 patients were treated with many kinds of the best supportive care without chemotherapy. The median survival was 29.1+/-2.7 months and 15.7+/-2.8 months, respectively. The median survival and disease free survival for the gemcitabine based chemotherapy group who received curative resection was 31.6+/-2.5 and 15.7+/-3.2 months, respectively. The median survival and disease free survival for the patients without chemotherapy after curative resection was 16.3+/-2.9 and 15.7+/-3.2 months, respectively. CONCLUSION: Patients with gallbladder cancer and who received adjuvant gemcitabine-based chemotherapy had a relatively favorable prognosis. Especially, gemcitabine-based combination chemotherapy could be effective and acceptable for the treatment of gallbladder cancer patients who have undergone curative resection.
Cisplatin ; Deoxycytidine ; Disease-Free Survival ; Drug Therapy, Combination ; Fluorouracil ; Gallbladder ; Gallbladder Neoplasms ; Humans ; Prognosis

A 54 year old man was referred to our hospital with gastric cancer. The patient had a history of splenectomy and a left nephrectomy as a result of a traffic accident 15 years earlier. The endoscopic findings were advanced gastric cancer at the lower body of the stomach. Abdominal ultrasonography (USG) and magnetic resonance imaging demonstrated a metastatic nodule in the S2 segment of the liver. Eventually, the clinical stage was determined to be cT2cN1cM1 and a radical distal gastrectomy, lateral segmentectomy of the liver were performed. The histopathology findings confirmed the diagnosis of intrahepatic splenosis, omental splenosis. Hepatic splenosis is not rare in patients with a history of splenic trauma or splenectomy. Nevertheless, this is the first report describing a patient with gastric cancer and intrahepatic splenosis that was misinterpreted as a liver metastatic nodule. Intra-operative USG guided fine needle aspiration should be considered to avoid unnecessary liver resections in patients with a suspicious hepatic metastasis.
Accidents, Traffic ; Biopsy, Fine-Needle ; Gastrectomy ; Humans ; Liver ; Magnetic Resonance Imaging ; Mastectomy, Segmental ; Neoplasm Metastasis ; Nephrectomy ; Splenectomy ; Splenosis ; Stomach ; Stomach Neoplasms

PURPOSE: Endocrine abnormalities are common feature of chronic renal failure. The purpose of this study is to understand women's hormonal changes in connection with renal transplantation and to verify improved quality of life of recipient by comparing level of sexual hormone between renal transplant recipients and dialyzed patients. METHODS: To evaluate the level of hormones before and after female renal transplantation, we measured FSH, LH, estradiol, progesterone and prolactin (PRL) in 10 renal transplant recipients (RTR), 10 chronic renal failure patients (CRF) undergoing dialysis (hemodialysis or peritoneal dialysis) and 10 healthy, regularly menstruating women (controls). RESULTS: All 30 females' mean age was 37.83 years. All 10 RTR were menstruating and mean age was 38.6 years and mean serum creatinine (sCr) level was 1.09 mg/dL. Of ten dialyzed patients (6 hemodialysis and 4 peritoneal dialysis), nine of ten dialyzed patients had menstrual disturbance and their mean age was 37.5 years and mean sCr level was 9.8 mg/dL. In RTR, serum PRL and LH level were reduced compared with CRF patients, but these hormones were increased compared with controls. In RTR, progesterone level was significantly lower compared with controls, whereas slightly decreased compared with CRF patients. Estradiol level in dialyzed patients was significantly higher compared with RTR or controls and in RTR was increased compared with controls. CONCLUSION: Following successful renal transplantation, uremic hormonal abnormalities were ameliorated. However, these hormonal changes are not always fully restored which can be attributed to renal insufficiency grade or result from the administered immunosuppressive treatment.
Creatinine ; Dialysis ; Estradiol ; Female* ; Humans ; Kidney Failure, Chronic ; Kidney Transplantation* ; Progesterone ; Prolactin ; Quality of Life ; Renal Dialysis ; Renal Insufficiency ; Transplantation

We present here a case of recurrent rectal cancer liver metastasis that was managed with ante situm liver resection under total vascular exclusion (TVE) and venovenous bypass with hypothermic perfusion. A 58-year-old man who suffered with rectal cancer liver metastasis was transferred to our hospital in January 2006. A left lateral sectionectomy had been previously performed. Recurrent lesion developed in segments I, IV and VIII one year after the first hepatectomy. The tumor was 5 cm in diameter and it involved the confluence of the hepatic veins and the retrohepatic vena cava. An incomplete tumor-free margin and massive bleeding were expected with performing a conventional liver resection, together with vena cava reconstruction. Therefore, we planned an ante situm liver resection under TVE and venovenous bypass with hypothermic perfusion. After adhesiolysis, hilar dissection was carried out. The inflow to the medial segment was interrupted, and then the liver and inferior vena cava (IVC) were mobilized fully. During controlling the bleeding of a short hepatic vein, we found adhesion of the hepatocaval portion. Therefore, TVE and venovenous bypass were performed along with suprahepatic IVC transection. The long conduit of V5 was preserved during hepatic parenchymal dissection, and the paracaval portion of the caudate lobe was readily detached from the IVC. The suprahepatic IVC was reconstructed after V5 reconstruction with using the saphenous vein. Portal vein anastomosis was then conducted. After reperfusion, an end-to-side anastomosis was performed between the saphenous vein graft and the IVC. Finally, a Roux-en-Y hepaticojejunostomy was carried out. The patient remains well without recurrence 12 months after the last operation.
Ants ; Hemorrhage ; Hepatectomy ; Hepatic Veins ; Humans ; Liver ; Middle Aged ; Neoplasm Metastasis ; Perfusion ; Portal Vein ; Rectal Neoplasms ; Recurrence ; Reperfusion ; Saphenous Vein ; Transplants ; Vena Cava, Inferior

A 53-year-old woman was diagnosed with gastrointestinal stromal tumor (GIST) of the stomach. Computed tomography (CT) revealed a huge mass (12 cm in diameter), likely to invade pancreas and spleen. In the operation field, the tumor was in an unresectable state. The patient was then started on imatinib therapy for 4 months. On follow-up imaging studies, the tumor almost disappeared. We performed total gastrectomy and splenectomy upon which two small-sized residual tumors were found on microscopy. In this paper, we describe a case of clinicopathologic change in unresectable GIST after neoadjuvant imatinib mesylate.
Benzamides ; Female ; Follow-Up Studies ; Gastrectomy ; Gastrointestinal Stromal Tumors ; Humans ; Imatinib Mesylate ; Mesylates ; Microscopy ; Middle Aged ; Neoplasm, Residual ; Pancreas ; Piperazines ; Pyrimidines ; Spleen ; Splenectomy ; Stomach

PURPOSE: The goal of oncoplastic breast surgery is to restore the appearance of the breast and improve patient satisfaction. Thus, the assessment of cosmetic results and patient-reported outcomes (PROs) using appropriately constructed and validated instruments is essential. The aim of the present study was to assess the long-term objective cosmetic results and corresponding PROs after oncoplastic breast surgery. METHODS: Cosmetic results were assessed by the patients, a medical panel, and a computer program (BCCT.core). PROs were assessed using BREAST-Q, a questionnaire that measures the perception of patients having breast surgery. The cosmetic results and PROs were analyzed in patients who underwent quadrantectomy and partial breast reconstruction utilizing the latissimus dorsi flap. RESULTS: The mean duration of the follow-up period was 91.6 months (range, 33.3-171.0 months), and mean age of the patients was 51 years old (range, 33-72 years). The mean tumor size was 2.1 cm (range, 0.9-5.5 cm). There was fair agreement between the medical panel and BCCT.core score (K = 0.32, P < 0.001), and a statistically significant correlation between the BCCT.core score and medical panel cosmetic results was identified (r = 0.606, P < 0.001). A better BCCT.core result was related to a higher PRO of each BREAST-Q domain-satisfaction with breasts (R2 = 0.070, P = 0.039), satisfaction with outcome (R2 = 0.087, P = 0.021), psychosocial well-being (R2 = 0.085, P = 0.023), sexual well-being (R2 = 0.082, P = 0.029), and satisfaction with information (R2 = 0.064, P = 0.049). CONCLUSION: Our long-term results of oncoplastic surgery achieved a high level of patient satisfaction with good cosmetic results. The medical panel and BCCT.core results correlated well with the PROs of the patients using valid, reliable, and procedure-specific measures.
Breast* ; Female ; Follow-Up Studies ; Humans ; Mammaplasty ; Patient Satisfaction ; Pilot Projects* ; Quality of Life ; Superficial Back Muscles* ; Surgical Flaps